-

Piper Sandler Appoints Michael Piper as Head of Fixed Income

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, has named Michael Piper as the head of fixed income, effective in the first quarter of 2026. He will report to Deb Schoneman, president at Piper Sandler. The previous head of fixed income, John Beckelman will transition to vice chairman of fixed income capital markets. He will continue to serve as a senior advisor to the business while focusing almost exclusively on client engagement.

“Mike has proven to be an effective leader, and we are excited for him to take the reins and grow the business to new heights,” said Deb Schoneman.

Share

“Mike has proven to be an effective leader, and we are excited for him to take the reins and grow the business to new heights. Over the past few years, he has successfully diversified our fixed income platform and led the effort to recruit outstanding professionals to join our team. I would like to thank John for leading our practice following the acquisition of Sandler and solidifying our position as one of the leading fixed income businesses in the industry,” said Schoneman.

Michael joined the firm as part of the Sandler O’Neill acquisition in 2020. At Sandler O’Neill, he held several roles in fixed income across management, sales, and trading. Prior to that, he was an analyst with Guggenheim Structured Product Asset Management and worked in investment strategy with Guggenheim Securities. Michael started his career at Bear Stearns focusing on the CLO/CDO market. He graduated from Tulane University with a bachelor's degree in finance and marketing.

“I’m honored to take on this new leadership role and look forward to building on our continued success. We have an incredible team in place, and I believe there are meaningful opportunities to enhance our offerings, while continuing to provide best-in-class service to our clients,” said Michael Piper.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, authorized and regulated by BaFin as a tied agent of AHP Capital Management GmbH; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | X

©2025. Since 1895. Piper Sandler Companies. 350 North 5th Street, Minneapolis, Minnesota 55401

Contacts

Nick Lawler
Tel: 212 891-8954
nick.lawler@psc.com

Piper Sandler Companies

NYSE:PIPR

Release Versions

Contacts

Nick Lawler
Tel: 212 891-8954
nick.lawler@psc.com

More News From Piper Sandler Companies

Piper Sandler Appoints Aamer Naseer to Head of Life Sciences Outsourcing and B2B Med Tech

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the appointment of Aamer Naseer to global head of life sciences outsourcing and B2B med tech. “Aamer has built deep relationships across the life sciences ecosystem and has a strong track record of advising private equity firms, public companies and founders/entrepreneurs. His leadership, sector expertise and commitment to our clients position us exceptionally well to continue e...

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Jason Arnold

MINNEAPOLIS & LONDON--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Jason Arnold as a managing director in the healthcare investment banking group. Arnold will be initially based in London while serving clients globally. He will be advising life science tools and diagnostic companies on mergers and acquisitions, strategic partnerships and capital raising transactions. “We’re delighted to welcome Jason to the healthcare i...
Back to Newsroom